COVID-19 Vaccinations, Infections, and Outcomes Among 784 People Living with HIV
Viruses · 2024
DOI: 10.3390/v16121805 ↗Kurz gefasst
Fachartikel in der Zeitschrift Viruses, 2024. Verfasst von Keren Mahlab-Guri und 9 weiteren Autor:innen. Beteiligte Einrichtung: Faculty of Medicine, Hebrew University of Jerusalem, Jerusalem 9112102, Israel. Hauptthemen laut MEDLINE: COVID-19, SARS-CoV-2, COVID-19 Vaccines, HIV Infections. Die Arbeit nennt 26 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Abstract (Originalsprache)
Introduction
Variants of COVID-19 are responsible for 700 million infections and 7 million deaths worldwide. Vaccinations have high efficiency in preventing infection and secondary benefits of reducing COVID-19 hospital admissions, attenuating disease severity and duration of illness. Conflicting reports were published regarding COVID-19 among PLWH.
Objective
The aim of this study was to evaluate COVID-19 morbidity, hospitalization, and the magnitude of immunological response to sequential BNT 162b2 mRNA vaccines in PLWH regarding demographic and clinical factors.
Results
Our retrospective study included 784 PLWH who had at least one anti- SARS-CoV-2 antibody test between March 2021 and October 2021. Half of our patients (392) had CD4 cell counts above 500 cells/µL, 40.2% (315) had 200 < CD4 < 500 cells/µL and only 9.8% (77) had CD4 < 200 cells/µL at their last laboratory workup. The mean age was 50.2 ± 12.2 years. About 90% of our patients were given at least two doses of the BNT 162b2 Pfizer vaccines; about 60% received three doses of the vaccine. About a quarter of our patients (27.6%) had COVID-19 infection. Only six patients required hospital admission. All six patients recovered from COVID-19 infection. Titers of COVID-19 antibodies were lower for patients with CD4 cell counts of less than 200 cells/µL in the first, second, and third serological tests with statistical significance. In a multinomial logistic regression, the influence of other factors such as age, sex, and previous COVID-19 infection on first COVID-19 antibody titers was not significant.
Conclusions
PLWH are responsive to COVID-19 vaccines. As was expected, patients with higher CD4 cell counts had higher titers of COVID-19 antibodies and lower hospitalization rate. Age, sex, and previous COVID-19 infection did not significantly affect antibody titers according to our study. Larger prospective studies with control groups are needed to further characterize immunologic response to COVID-19 vaccination among PLWH.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Faculty of Medicine, Hebrew University of Jerusalem, Jerusalem 9112102, Israel.
- Allergy, Clinical Immunology and AIDS Center, Kaplan Medical Center, Rehovot 7680400, Israel.
ORCID-Profile: Ramon Cohen, Daniel Elbirt
Zitieren
APA
Mahlab-Guri, K., Komarova, I., Kadar, L., Nemet, S., Cohen, R., Radian-Sade, S., Tova, A., Guri, A., Rosenberg-Bezalel, S., & Elbirt, D. (2024). COVID-19 Vaccinations, Infections, and Outcomes Among 784 People Living with HIV. Viruses. https://doi.org/10.3390/v16121805
Vancouver
Mahlab-Guri K, Komarova I, Kadar L, Nemet S, Cohen R, Radian-Sade S, et al. COVID-19 Vaccinations, Infections, and Outcomes Among 784 People Living with HIV. Viruses. 2024. doi:10.3390/v16121805
BibTeX
@article{MahlabGuri2024,
author = {Mahlab-Guri, Keren and Komarova, Irina and Kadar, Laliv and Nemet, Shay and Cohen, Ramon and Radian-Sade, Sara and Tova, Achiel and Guri, Alex and Rosenberg-Bezalel, Shira and Elbirt, Daniel},
title = {COVID-19 Vaccinations, Infections, and Outcomes Among 784 People Living with HIV},
journal = {Viruses},
year = {2024},
doi = {10.3390/v16121805}
}
EUVIMED